Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by ISOMÄKI, P.
Right arrow Articles by TOIVANEN, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ISOMÄKI, P.
Right arrow Articles by TOIVANEN, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 British Society for Rheumatology

research-article

EXPRESSION OF bcl-2 IN RHEUMATOID ARTHRITIS

P. ISOMÄKI*, K.-O. SÖDERSTRÖM,{dagger}, J. PUNNONEN*, A. ROIVAINEN*, R. LUUKKAINEN, R. MERILAHTI-PALO{ddagger},§, S. NIKKARI*, O. LASSILA* and P. TOIVANEN*

*Turku Immunology Centre and Department of Medical Microbiology Turku
{dagger}Department of Pathology Turku
{ddagger}Department of Medicine, Turku University Turku
§Turunmaa Hospital Turku
¶Satalinna Hospital Harjavalta, Finland

Correspondence to: Correspondence to: P. Isomäki, Department of Medical Microbiology, Turku University, FIN-20520 Turku, Finland.

Since defective apoptosis has been suggested to play a role in the development of autoimmune diseases, we have investigated the expression of the proto-oncogene bcl-2 in patients with rheumatoid arthritis (RA). The expression of bcl-2 was studied in peripheral blood (PB) and synovial fluid (SF) lymphocytes and synovial tissues (ST) from patients with RA using immunohistochemistry, flow cytometry and nucleic acid hybridization. Patients with reactive arthritis (ReA) or osteoarthritis (OA) and healthy individuals were used as controls. The expression of bcl-2 protein in PB lymphocytes and the expression of bcl-2 mRNA in PB mononuclear cells (PBMC) was similar in healthy controls and patients with RA. However, bcl-2 protein expression was significantly reduced in SF lymphocytes when compared to PB lymphocytes. Similar results were observed with lymphocytes from patients with ReA, and irrespective of whether total lymphocytes, T cells or different T-cell subsets were studied. In the synovial sections, the expression of bcl-2 was restricted to lymphocytes, and bcl-2+ cells were observed in the majority of samples from patients with RA, OA and ReA. These data indicate that the expression of bcl-2 is not increased in the lymphocytes or ST derived from patients with RA. Instead, decreased expression of bcl-2 protein in SF lymphocytes compared to PB lymphocytes was demonstrated. We suggest that bcl-2 does not play a significant role in the pathogenesis of RA.

KEY WORDS: bcl-2, Rheumatoid athritis, Lymphocytes


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
M. Aringer, G. H. Stummvoll, G. Steiner, M. Koller, C. W. Steiner, E. Hofler, H. Hiesberger, J. S. Smolen, and W. B. Graninger
Serum interleukin-15 is elevated in systemic lupus erythematosus
Rheumatology, August 1, 2001; 40(8): 876 - 881.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.